---
$id: https://graph.org.ai/products/commodity/51141586
$type: Product
source: UNSPSC
code: "51141586"
title: "Zoniclezole"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zoniclezole

**UNSPSC Code**: 51141586
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C12H10ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1C5F0K79E, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but generally known as zoniclezole, which bears US NIH Compound Identifier 60745. European Medicines Agency schedules Zoniclezole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00186MIG. The term ZONICLEZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). ZONICLEZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zoniclezole under HS 29349990 and SITC 51579. As of Q4 2014, ZONICLEZOLE remains the US FDA Preferred Term for this commodity. Zoniclezole bears US NLM identifiers UMLS ID C0656178 and NCI Concept Code C82235. SMILES: CC(C1=NOC2=C1C=C(C=C2)CL)N3C=CN=C3.

